Journal
POSTGRADUATE MEDICAL JOURNAL
Volume 84, Issue 991, Pages 246-251Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/pgmj.2007.066589
Keywords
-
Categories
Ask authors/readers for more resources
Positron emission tomography ( PET) using F-18-fluorodeoxyglucose (F-18-FDG) has been widely used not only for detecting and staging malignant tumours but also for monitoring therapy response and for differentiating malignant lesions from benign lesions. However, the sensitivity of F-18-FDG PET for hepatocellular carcinoma (HCC) is low. Recent research about the novel drug shows that the sensitivity of C-11-acetate PET for HCC is higher than that of F-18-FDG PET and C-11-acetate also indicates tumour cell differentiation. F-18-FDG PET proved to be highly sensitive in detecting hepatic metastases from different primaries. F-18-FDG PET has also been shown to be useful and more accurate than conventional imaging modalities in demonstrating the effect of local treatments in liver tumours. With the development of small animal imaging, animal research about F-18-FDG PET is increasing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available